Paris and Boston, April 30, 2024 – 5:45 p.m. CEST – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that it has published its Annual Financial Report for the year ended 31 December 2023 and filed it with the Autorité des Marchés Financiers (AMF) on 30 April 2024.
This report can be consulted on the Mauna Kea Technologies website, in accordance with current regulations. It can be consulted or downloaded at www.maunakeatech.com in the Investors > Financial Documents section, as well as on the AMF website (www.amf-france.org).
***
Financial calendar :
- Annual General Meeting, on 6 June 2024
- Sales for the 2nd quarter and 1st half of 2024, on 25 July 2024, after market close
